Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

This study has been terminated.
(This study has been terminated.)
Information provided by:
SBI Biotech Co., Ltd. Identifier:
First received: December 17, 2009
Last updated: December 22, 2014
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)